Methadone Market

Global Methadone Market Size (2023 to 2028)

As per our report, the global methadone market size is estimated to grow at a robust CAGR during the forecast period.

Methadone is a medication that is used to treat chronic pain. It is a substitute for morphine or opioid drugs in the treatment of addiction disorders and is safer than other narcotics drugs due to its sedative nature. The methadone drug is available in a variants dosage form such as tablets, capsules, and liquids and injectable. It blocks the action of high form drugs like codeine, morphine and heroin. The patients having a chronic disease pain can use a small dose of methadone for their pain relief. 

An increasing number of patients associated with therapeutics pain treatment, cancer and other chronic diseases pain are factors driving the global market of methadone drug. The availability of the drug in various dosage forms and increasing awareness of side effects with narcotics drugs is raising the demand for methadone drug. Increasing incidents of narcotics abuse, and growing heroin-addicted people are fuelling the global methadone market. Rising awareness of methadone drug into the market is further accelerating the market growth. 

However, in the methadone administration, some patients have problems related to respiratory disorders such as difficulty in breathing and severe- asthma could hamper the global methadone market. 

COVID 19 IMPACT ON METHADONE MARKET

The continuous spread of the novel coronavirus (COVID 19) pandemic has disrupted care provision in patients with disorders. The coronavirus is spreading to every corner of the world. The new coronavirus and lockdown have made life very difficult for humans, and intensifying drug usage is very harmful. The accomplishment of online appointments to get methadone with accurate dosage is essential to diminish cross-contact patients' threat to clinics. Amid the pandemic period, there is an accumulating mortality rate in people with opioid use disorder with COVID 19. In the U.S., the opioid widespread has dramatically worsened by the COVID 19. The worldwide spread of COVID 19 results in disruptions in the drug and medication supply chain outside the U.S. Ability improvements include growing delivery of take-home doses and the usage of office-based treatment. The present COVID 19 impacts people with opioid use disorder, restrictions that continue, and the opportunities that develop regulations around treatments for this population are eased. In the light of the pandemic, most of the patients recovering from opioid addiction may be suitable to take methadone and other treatment drugs at home rather than in clinics. This is ascribed to boost up the growth rate of the methadone market.

REPORT COVERAGE

This research report on the global methadone market has been segmented and sub-segmented into the following categories.

Methadone Market - By Application:                 

• Operation
• Detoxification        
• Others      

Based on the application, the operation segment is accounted for the majority of the shares in the market in 2022. The growth is due to growing occurrences of opioid abuse and increasing usage of drugs.

Methadone Market - By Mode of Administration:             

• Injections                
• Oral Medicine        
  • Tablets
  • Liquid

Based on the mode of administration, the oral medicines segment is expected to be the most lucrative segment in the market. The factors such as accessibility of the drugs in different kinds and dosages and increasing geriatric population are propelling the demand of the market.

Regional Analysis

Regionally, the global methadone market is mostly dominated by North America and owes to have the highest share of the market over the analysis period. The growth is credited due to high preponderance of distress and increasing occurrences of drug addiction. Within North America, the U.S. is leading with the largest share of the methadone market due to the growing phenomenon of addiction and growing occurrences of people utilization methadone of chronic pains.

Europe is estimated to be the second most prosperous region in the global methadone market. The growth of this region is caused due to high obtainment of analgesics. Factors like the growing number of people with chronic pain are expected to fuel the market growth. Moreover, adverse effects related to the usage of methadone market are hampering the market.

Asia Pacific region is expected to have the fastest growth rate during the forecast period, owing to the rising incidence of drug abuse in the area. Asia-Pacific region is expected to the quickest growing rate of methadone market. In countries like India and China, the growth is due to massive increasing population. The rise in the number of people getting affected with chronic pain is considering to propel the market growth.

Latin America region is estimated to have a steady growth over the methadone market. The growth of this market is attributed due to growing awareness towards the use of medication, and growing drug addictions are surging the market growth.

The Middle East & Africa is believed to be the least growing sector in the methadone market and is due to lower acquisition. The market growth is accredited due to the large number of people who got addicted to several opioids like heroin and morphine. Increasing awareness towards the use of medications and growth in several people are expected to propel the demand of the market in this region.

TOP COMPANIES IN THE MARKET

Some of the major players in the global methadone market profiled in the report are Diskets, Methadoes, Aurolife Pharma LLC., Macfarlan Smith, VistaPharm, Qinghai Pharm, CentralPharm, Mallinckrodt and Roxane (Boehringer Ingelheim).

RECENT MARKET DEVELOPMENTS

In 2019, All India Institute of Medical Science (AIMS) had launched new mobile vans treatment for opioids addicted patients in this year. The institute wants to reduce opioids addiction in India, so the methadone drug provided to patients in different dosage forms to the patients. 

In 2018, Elite pharmaceutical partnered with Glenmark pharmaceutical to launch new generic methadone hydrochloride tablet into the market that will be used to reduce the opioids abuse patients. The methadone hydrochloride used in the long term opioids treatment, also used in various therapeutic segments such as detoxification, maintenance therapy and addiction of narcotics drugs.

In 2018, BayMark Health service purchased Canadian addiction treatment centre that includes the number of hospitals and clinics, few pharmacies, and one residential centre. The US addiction treatment company has bought the Canadian methadone clinics market chain.